Archive for July, 2009
Joe M. Allbaugh, Former Fema Director, Joins Emergent Biosolutions’ Board Of Directors
Emergency Preparedness Expert to Assist Emergent’s Commitment to Protecting Military and First Responders Against Biological Threats
GAITHERSBURG, MD., July 12, 2006 — Emergent BioSolutions today announced that Joe M. Allbaugh, who served as the Director of the Federal Emergency Management Agency (FEMA) under President George W. Bush from 2001 to 2003, has joined its Board of [...]
In: Board of directors, Emergent BioSolutions, Fuad El-Hibri · Tagged with: Chief executive officer, Emergency management, Federal Emergency Management Agency, George W Bush, Joe Allbaugh, Oklahoma City, September 11 attacks, United States
Emergent Biosolutions Delivers Over 3 Million Doses Of Biothrax® To U.S. Department Of Health And Human Services For Strategic National Stockpile
Delivery represents approximately $75 million of revenue for 4Q 2006; Company on track to deliver remaining 1 million doses in 1Q 2007—
GAITHERSBURG, MD, December 14, 2006—Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has successfully completed the 4Q 2006 deliveries of over three million doses of BioThrax® (Anthrax Vaccine Adsorbed), the only FDA licensed [...]
In: Biothrax, Emergent BioSolutions, Fuad El-Hibri, Strategic National Stockpile, U.S. Department Of Health And Human Services
Jerome M. Hauer Named To Board Of Directors Of Emergent Biosolutions
Gaithersburg, MD, June 8, 2005– Emergent BioSolutions announced today that Jerome M. Hauer, former acting Assistant Secretary for the Office of Public and Emergency Preparedness in the U.S. Department of Health and Human Services, has been named to its board of directors.
“Jerry’s distinguished career in the field of emergency preparedness at all levels of government [...]
In: Board of directors, Chief executive officer, Emergent BioSolutions, Fuad El-Hibri · Tagged with: Emergent BioSolutions, George Washington University School of Public Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, New York City Mayor, Rudy Giuliani, United States Department of Health and Human Services
Cornerstone Ceremony Welcomes New Vaccine Production Facility To Michigan
Emergent BioSolutions’ $75 Million Investment and Commitment to Michigan Applauded by Governor Granholm
LANSING, MI, July 21, 2006 – Emergent BioSolutions, a biopharmaceutical company, announced today the dedication of a new large-scale vaccine production facility for its BioDefense Operations in a gala ceremony on its Lansing, Michigan campus. This $75 million dollar project represents a significant [...]
In: Emergent BioSolutions, Fuad El-Hibri · Tagged with: Business and Economy, Chief executive officer, Government, Jennifer Granholm, Lansing Michigan, Michigan, Society and Culture, United States
Emergent Biosolutions Acquires Microscience, An Innovative, UK-Based Vaccine Company
Strategic Acquisition Strengthens Emergent’s Commercial Pipeline and Creates Significant European Presence To Serve Growing Global Vaccine Market Adds Proprietary Platform Technology in Oral Vaccine Delivery and Identification of Vaccine Targets
GAITHERSBURG, MD, June 27, 2005 —Emergent BioSolutions today announced that it has acquired UK-based Microscience, Ltd., a privately-held vaccine company primarily involved in the research and [...]
In: Chief executive officer, Emergent BioSolutions, Fuad El-Hibri · Tagged with: Biotechnology and Pharmaceuticals, Business, Chief executive officer, Clinical trial, Company, Research and development, United States
Emergent Biosolutions Celebrates Initial Public Offering; Ceo To Ring Opening Bell On The NYSE
Image via Wikipedia
GAITHERSBURG, MD., November 21, 2006—Emergent BioSolutions Inc. (NYSE: EBS), a biopharmaceutical company that develops vaccines and therapeutics for biodefense and commercial applications and manufactures the only anthrax vaccine approved by the (FDA), today announced it will be celebrating the Company’s recently completed initial public offering with the ringing of the opening bell [...]
In: Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, NYSE Opening Bell, U.S. Food and Drug Administration · Tagged with: Biotechnology and Pharmaceuticals, Business, Chief executive officer, Clinical trial, Company, Emergent BioSolutions, New York Stock Exchange, Private Securities Litigation Reform Act, U.S. Food and Drug Administration
Emergent Biosolutions Expands Presence In Germany
Acquires Vivacs GmbH Along with Rights to Modified Vaccinia Virus Ankara (MVA) Strain and Monoclonal Vector Technology Platform (MVAtorTM)
GAITHERSBURG, MD., August 03, 2006—Emergent BioSolutions Inc., a privately held biopharmaceutical company, today announced it has completed the acquisition of Vivacs GmbH, a privately held biotechnology company based in Munich, Germany. Financial details of the transaction were [...]
In: Emergent BioSolutions, Fuad El-Hibri, Vivacs GmbH · Tagged with: Biotechnology and Pharmaceuticals, Business, Chief executive officer, Emergent BioSolutions, Germany, Infectious disease, Maryland, Munich
Emergent Biosolutions Announces Appointment Of Dr. Steven Chatfield As Chief Scientific Officer
Gaithersburg, MD, January 10, 2005–Emergent BioSolutions Inc., today announced the appointment of Dr. Steven Chatfield as its chief scientific officer. As Chief Scientific Officer, Dr. Chatfield will lead a team of more than 40 scientists within Emergent’s subsidiary companies, providing oversight in several areas, including early stage research, product development and clinical research.
Dr. Chatfield has [...]
In: Chief Scientific Officer, Emergent BioSolutions, Fuad El-Hibri · Tagged with: Biotechnology and Pharmaceuticals, Business, Chief executive officer, Clinical trial, Research and development, United States, University of Birmingham
Emergent Biosolutions And Hpa Announce Botulinum Vaccine Collaboration
Image via Wikipedia
Botulism Ranks In Cdc’S Category “A” Threat List For Bioweapons
Gaithersburg, MD and London, England—Emergent BioSolutions and the Britishbased Health Protection Agency (HPA) today announced a two-year collaboration for the development of vaccines to prevent botulism.
These two leaders in biodefense vaccines have long-established capabilities in the prevention of botulism dating to the 1950s. In [...]
In: Botulinum Vaccine, Emergent BioSolutions, Fuad El-Hibri · Tagged with: CDC, Centers for Disease Control and Prevention, Emergent BioSolutions, Gulf War, Health, Health Protection Agency, Infectious disease, US